Skip to main content

and
  1. No Access

    Article

    Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life—experience of the French Network

    We analysed the therapeutic outcomes of all consecutive patients with primary central nervous system lymphoma (PCNSL) registered in the prospective French database for PCNSL and treated with intensive chemothe...

    Laurence Schenone, Caroline Houillier, Marie Laure Tanguy in Bone Marrow Transplantation (2022)

  2. No Access

    Article

    Complement System: a Neglected Pathway in Immunotherapy

    Approved for the treatment of autoimmune diseases, hematological malignancies, and solid cancers, several monoclonal antibodies (mAb) make use of complement in their mechanism of action. Such an assessment is ...

    Anne Bordron, Cristina Bagacean in Clinical Reviews in Allergy & Immunology (2020)

  3. Article

    Open Access

    A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

    Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple my...

    Thierry Facon, Meletios A. Dimopoulos, Nathalie Meuleman, Andrew Belch in Leukemia (2020)